// App-Quantinova.ai

TCT-48 : Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT

Researchers

Presenter

  • Robert-Jan van Geuns

Principal Investigators

  • Chun-Chin Chang

  • Bernard Chevalier

  • Tommaso Gori

  • Emanuele Barbato

  • Giuseppe Tarantini

  • Stephan Achenbach

  • Dariusz Dudek

  • Javier Escaned

  • Mohamed Abdel-Wahab

  • Giovanni Esposito

  • Jan Tijssen

  • Marie-Claude Morice

  • Yoshinobu Onuma

  • Pieter Smits

Medical Centers

  • Radboud University Medical Center, Njmegen, Netherlands

  • University Medical Center Mainz, Mainz, Germany

  • Maasstad Ziekenhuis, Rotterdam, Netherlands

  • AMC, Naarden, the Netherlands

  • Heart Center Leipzig, University Hospital, Leipzig, Germany

  • nd Department of Cardiology Jagiellonian University Medical College, Cracow, Poland

  • Hospital Clínico San Carlos, IdISSC, Madrid, Spain

  • Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands

  • Friedrich-Alexander-Universitaet, Erlangen, Germany

  • Ramsay Générale de Santé, Institut Cardiovasculaire Paris-Sud, Massy, France

  • University of Naples Federico II, Dot of Advanced Biomedical Sciences, Naples, Naples, Italy

  • CERC, Massy, France

  • Cardiovascular Research Center Aalst OLV Hospital, Aalst, Belgium

  • University of Padova, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy

Locations

  • Netherlands

  • Poland

  • Italy

  • Belgium

  • Germany

  • France

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved